Navigation Links
Xlumena, Inc. Closes $7M Series B Venture Financing Round
Date:4/28/2011

MOUNTAIN VIEW, Calif., April 28, 2011 /PRNewswire/ -- Xlumena, a privately held provider of innovative technology for the interventional endoscopist and endoscopic surgeon, today announced it has successfully closed its Series B financing.

The current round of financing was led by new investor, Aperture Venture Partners, LLC and joined by Western Technology Investment. In conjunction with the financing, Eric Sillman of Aperture Venture Partners and Avi Kometz, MD of Ascent Biomedical Ventures will join Xlumena's Board of Directors.  "Xlumena has tremendous potential to deliver innovative devices to the emerging field of interventional and therapeutic endoscopy.  We are excited to lead the Series B financing and to begin collaborating with Xlumena's team to expand the impact of their novel technologies," stated Eric Sillman, General Partner of Aperture Venture Partners.

Also participating in the current round of financing were existing institutional investors Prism Ventures, Charter Life Sciences and Ascent Biomedical Ventures. "We are pleased to close our Series B with Aperture as the lead. This financing will support our market introductions in the US and Europe.  We are very fortunate to have top-tier investors supporting Xlumena's growth," stated Michael Allen, President and CEO of Xlumena.

About Xlumena, Inc.

Xlumena, Inc. is a privately-held interventional endoscopy-focused medical device company based in Mountain View, California.  The Company has a number of advanced therapeutic devices in various stages of development, including the NAVIX™ Access Device (FDA-cleared) and the AXIOS™ Stent and Delivery System (CE marked).  Formed in 2008 by Kenneth Binmoeller, MD (California Pacific Medical Center) and Michael Allen, Xlumena has raised $19M from venture capital sources to date.

For more information: http://xlumena.com  


'/>"/>
SOURCE Xlumena, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. CoDa Therapeutics Closes $19 Million Series B Financing Round
2. Benvenue Medical Closes $35.5 Million Series C Financing
3. PixelOptics Closes $45 Million Financing
4. AnaBios Corporation Closes Series A Financing
5. OncoSec Medical Closes Purchase and License Agreement for Tumor Therapy Technology with Inovio Pharmaceuticals
6. OncoSec Medical Closes $1.1M Financing
7. Patient Safety Technologies, Inc. Closes $7.1 Million Common Stock Offering
8. BridgePoint Medical Closes $9.1 Million Series C Financing
9. Palatin Technologies, Inc. Closes $23 Million Public Offering
10. Sonoma Orthopedic Products® Closes $22 Million Series D Financing
11. Rock Creek Pharmaceuticals Discloses Filing of Provisional Patent Application For Isolated Anatabine Isomer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... 2016 Australia Glaucoma Surgery Devices Market ... report, "Australia Glaucoma Surgery Devices Market Outlook to ... Glaucoma Surgery Devices market. The report provides value, ... and average prices (USD) within market segement - ... company shares and distribution shares data for each ...
(Date:12/8/2016)... 8, 2016 Global Interventional Radiology Market: ... global interventional radiology market analyzes the current and ... an elaborate executive summary, including a market snapshot ... sub-segments. The research is a combination of ... bulk of our research efforts along with information ...
(Date:12/8/2016)... 8, 2016  Diplomat Pharmacy, Inc. (NYSE: DPLO) has been recognized ... Top Workplaces National Standard. To learn more about ... ... Inc.) ... survey administered by WorkplaceDynamics, LLC, a research firm specializing in organizational ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... December 09, 2016 , ... The Pennsylvania Athletic Trainers’ ... during the summer of 2016. The program was made possible by a Pennsylvania ... Department of Health and Human Services Administration. The broadcast, Use Your Head: ...
(Date:12/8/2016)... ... December 08, 2016 , ... Russ DiGilio ... the first national #QuackGivesBack campaign which supported local breast cancer organizations during National ... Quack Gives Back initiative, and we’re very pleased with the participation ...
(Date:12/8/2016)... ... December 08, 2016 , ... CURE Media Group, the ... advocacy groups, has aligned with Upstage Lung Cancer in efforts to combat lung cancer, ... Michael J. Hennessy, Jr said, “CURE Media Group is honored to team up with ...
(Date:12/8/2016)... Fla (PRWEB) , ... December 08, 2016 , ... ... smarter modes of access for customers and employees that are both engaging and ... 7 with Service Smart Technology, the software company revealed today its plans to ...
(Date:12/8/2016)... ... December 08, 2016 , ... STAT courier is pleased to announce ... service for Texas, they are expanding their presence in Dallas. One of the most ... will bring new jobs to the Dallas and Forth Worth market. STAT takes pride ...
Breaking Medicine News(10 mins):